JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 20, 2016 | $1,260,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 20, 2016 | $1,210,000 | Yes |
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
- Issues related to Trans-Pacific Partnership agreement. - Issues related to Transatlantic Trade and Investment Partnership. - Issues related to the appointment of a dedicated healthcare trade official
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Copyright/Patent/Trademark CPT
- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES NAU | — |
Health Issues HCR
- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - S. 1622, "The FDA Devise Accountablility Act", regarding all provisions. - S. 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| ANNE BRUCE | — |
| BRIAN BURNS | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| BRIAN T KELLY | — |
| CHARLES NAU | — |
| MARK REESE | — |
Medicare/Medicaid MMM
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| ANNE BRUCE | — |
| BRIAN T KELLY | — |
| MARK REESE | — |
Budget/Appropriations BUD
- HR 83, "Consolidate and Further Continuing Appropriations Act, 2015", provisions related to emergency supplemental funding to address the Ebola epidemic domestically and internationally. - Issues related to the funding of the Biomedical Advanced Research and Development Authority. - FDA Funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BURNS | — |
| DARREL C JODREY | — |
| CHARLES NAU | — |
Environment/Superfund ENV
- HR 1321, "Microbead-Free Waters Act of 2015", regarding all provisions. - S 697, "Frank R. Lautenberg Chemical Safety for the 21st Century Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Insurance INS
- S 620, "Preserving Employee Wellness Programs Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Taxation/Internal Revenue Code TAX
- HR 1270/S 709, "Restoring Access to Medication Act of 2015", regarding all provisions. - Issues related to tax reform. - Issues related to CFC Look through permanency. - Issues related to R&D credit. - Issues related to Mobile Workforce legislation. - Issues related to Cadillac Tax. - Issues related to OECD tax reporting. - Issues related to Repatriation holiday. - Issues related to Puerto Rico tax treatment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
Animals ANI
- Issues relating to animal testing. - HR 2858, "Humane Cosmetics Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.